Back to top

Zacks.com Most Recent Articles

Zacks Equity Research

Hovnanian (HOV) Surpasses Q4 Earnings and Revenue Estimates

Tale of the Tape

Hovnanian (HOV) delivered earnings and revenue surprises of +846.03% and +0.42%, respectively, for the quarter ended October 2025. Do the numbers hold clues to what lies ahead for the stock?

HOVNegative Net Change LENNegative Net Change

Zacks Equity Research

Alexandria Cuts Dividend Amid Deepening Life Science Strains

Analyst Blog

ARE's steep dividend cut underscores deep strain from collapsing life science demand and forces it into asset sales and tighter cost controls.

TRNOPositive Net Change ARENegative Net Change WPCPositive Net Change

Zacks Equity Research

Hormel Foods Q4 Earnings Beat Estimates, Sales Increase Y/Y

Analyst Blog

HRL posts a fourth-quarter earnings beat and modest sales growth, as segment results reveal mixed trends across retail, foodservice and international.

HRLPositive Net Change CHEFPositive Net Change LWNegative Net Change VFFNegative Net Change

Zacks Equity Research

Can Sterling's Transportation Benefit From Federal Funding in 2026?

Analyst Blog

STRL's Transportation unit heads toward 2026 with a strong backlog and steady bids as federal funding enters its final stretch.

FLRPositive Net Change ACMPositive Net Change KBRPositive Net Change STRLPositive Net Change

Zacks Equity Research

BMY Gains on News of Continuation of Alzheimer's Disease Study

Analyst Blog

Bristol Myers jumps after choosing to continue its phase III ADEPT-2 study on Cobenfy for Alzheimer-related psychosis, delaying data to next year.

BMYPositive Net Change FOLDPositive Net Change ANIPNegative Net Change CRMDPositive Net Change

Amit Kr Ram

EMCOR Stock Dips 9% in a Month: Should Investors Hold or Fold?

Analyst Blog

EME faces margin and timing headwinds, yet data center demand and acquisitions continue to reinforce its long-term positioning.

PWRPositive Net Change EMEPositive Net Change FIXPositive Net Change MTZPositive Net Change

Moumi Mondal

Hologic's BCI Test Shows Growing Impact in Endocrine Therapy Decisions

Analyst Blog

HOLX's BCI test gains traction as new SABCS studies are set to highlight its growing role in guiding extended endocrine therapy decisions.

BDXNegative Net Change MDTPositive Net Change HOLXPositive Net Change

Zacks Equity Research

APPS' AGP Growth Fueled by Rising Ad Impressions: What's Next?

Analyst Blog

Digital Turbine's AGP business surges on a 30% jump in ad impressions, fueled by wider SDK reach, non-gaming gains and strong APAC momentum.

APPPositive Net Change APPSPositive Net Change UNegative Net Change

Mrithunjoy Kaushik

Chipotle Recalibrates Pricing Playbook as Inflation Pressures Build Up

Analyst Blog

CMG reshapes its pricing playbook, leaning on slower, phased increases as inflation builds and value protection takes center stage.

BJRINegative Net Change MCDPositive Net Change CMGNegative Net Change

Zacks Equity Research

Best Momentum Stocks to Buy for Dec.4

Zacks #1 Rank Additions

ZTO and BG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Dec. 4, 2025.

BGNegative Net Change ZTOPositive Net Change

Mrithunjoy Kaushik

CCL's ROIC Climbs to 13%: Is a New Profitability Cycle Taking Shape?

Analyst Blog

Carnival's ROIC hits its highest level since 2007, signaling stronger returns as efficiency gains, debt cuts and fleet upgrades reshape its recovery path.

CCLNegative Net Change RCLNegative Net Change NCLHNegative Net Change

Zacks Equity Research

Stanley Black Exhibits Strong Prospects Despite Persisting Headwinds

Analyst Blog

SWK pushes toward $2B in cost savings as supply-chain actions, portfolio moves and shareholder returns reshape its long-term outlook.

SWKNegative Net Change DOVNegative Net Change CRPositive Net Change HLIONegative Net Change

Zacks Equity Research

How is Rivian Addressing Its Delivery Van Seat Belt Issue?

Analyst Blog

RIVN moves to fix a seat belt defect in its delivery vans with an OTA update and free pretensioner replacements after a major recall.

FPositive Net Change STLAPositive Net Change RIVNPositive Net Change

Zacks Equity Research

Can USA Rare Earth's Stillwater Facility Fuel Its Near-Term Momentum?

Analyst Blog

USAR advances its Stillwater plant toward commercial NdFeB magnet production, backed by fresh capital and a key acquisition.

TMQPositive Net Change NBPositive Net Change USARPositive Net Change

Zacks Equity Research

THOR Q1 Earnings Surpass Expectations, Revenues Rise Y/Y

Analyst Blog

THO's Q1 earnings top expectations as revenues rise and motorized and European RV gains balance uneven margins and shifting backlogs.

THOPositive Net Change GMPositive Net Change KARNegative Net Change GTXPositive Net Change

Tanvi Sarawagi

Can GE Vernova's R&D Pipeline Boost Its Clean-Energy Position?

Analyst Blog

GEV ramps up R&D and capital investments to drive the energy transition as its rising earnings estimates draw attention.

SBGSYPositive Net Change SIEGYPositive Net Change GEVPositive Net Change

Tanvi Sarawagi

KTOS Stock Rises 14.4% in 3 Months: What's the Next Best Move?

Analyst Blog

Kratos Defense rallies as new facilities, strong drone demand and a solid backlog boost its defense footprint and prospects.

AVAVPositive Net Change CWPositive Net Change KTOSPositive Net Change

Zacks Equity Research

Huntington Ingalls Secures Contract to Support Aircraft Carrier

Analyst Blog

HII secures a nearly $91.9M Navy contract for Nimitz and Ford-class carriers, with options lifting its value to about $472M.

LMTPositive Net Change GDPositive Net Change BAESYPositive Net Change HIIPositive Net Change

Zacks Equity Research

Chevron Announces a Disciplined $18-$19B Capex Plan for 2026

Analyst Blog

CVX unveils a focused 2026 capex plan emphasizing high-return U.S. shale, offshore growth in Guyana and continued investments in lower-carbon initiatives.

CVXPositive Net Change PARRNegative Net Change VISTPositive Net Change DTIPositive Net Change

Sraddha Singha

Stride is Trading at a Discount: Right Time to Buy the Stock?

Analyst Blog

LRN trades at a deep discount, but platform failures threaten near-term growth. Can its Career Learning engine still drive the path to 2028 targets?

STRAPositive Net Change LOPEPositive Net Change LRNNegative Net Change ATGEPositive Net Change

Subham Roy

Should You Hold or Fold EXOD Stock After a 38.3% Decline in a Month

Analyst Blog

Exodus Movement's sharp drop meets rising revenues, strong assets and new payments expansion - raising the question of whether the slide signals opportunity.

PYPLNegative Net Change COINPositive Net Change HOODPositive Net Change EXODPositive Net Change

Sraddha Singha

Can Dycom Offset Wireless Softness With Surging Fiber Demand?

Analyst Blog

Can DY's fiber surge, BEAD tailwinds and expanding data-center exposure keep powering its breakout despite a premium valuation and wireless softness?

PWRPositive Net Change DYPositive Net Change MTZPositive Net Change

Zacks Equity Research

NOV Stock Up 33% in 6 Months: Should Investors Hold or Move On?

Analyst Blog

NOV stock is up, but tariff costs, margin pressures and weak near-term demand temper momentum. Strong offshore backlogs still support its long-term potential.

NOVNegative Net Change OISPositive Net Change USACNegative Net Change SEIPositive Net Change

Zacks Equity Research

Honeywell's Losing Grip in Industrial Automation: What's Impeding Its Growth?

Analyst Blog

HON's Industrial Automation slump deepens as sensing, safety and productivity sales weaken despite strength in aerospace.

HONNegative Net Change MMMNegative Net Change RBCPositive Net Change

Zacks Equity Research

Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know

Analyst Blog

ZTS faces steep YTD losses as safety concerns hit key osteoarthritis therapies, forcing revenue cuts while new approvals aim to stabilize growth.

ZTSNegative Net Change CRMDPositive Net Change ADMAPositive Net Change ARQTPositive Net Change

Avisekh  Bhattacharjee

Axon Plunges 31.1% in 6 Months: Should You Hold or Fold the Stock?

Analyst Blog

AXON's 31% slide contrasts with strong device and software growth as rising costs, debt and valuation cloud near-term sentiment.

TDYPositive Net Change KTOSPositive Net Change AXONPositive Net Change

Zacks Equity Research

PKX and Factorial Partner to Advance Battery Materials Development

Analyst Blog

PKX teams up with Factorial to develop all-solid-state battery materials, aiming to boost safety, energy density and next-gen mobility performance.

PKXNegative Net Change KGCPositive Net Change HMYNegative Net Change FSMNegative Net Change

Kinjel Shah

3 Large Drug Stocks to Watch as the Industry Shows Some Recovery

Industry Outlook

In the Large-Cap Pharmaceuticals industry, Lilly, J&J and Sanofi are worth retaining as the industry shows some recovery.

LLYNegative Net Change SNYNegative Net Change JNJNegative Net Change

Zacks Equity Research

Company News for Dec 4, 2025

Corporate Summary

Companies In The Article Are:RY, CXM, OKTA, MRVL

MRVLNegative Net Change RYPositive Net Change OKTAPositive Net Change CXMPositive Net Change

Zacks Equity Research

The Zacks Analyst Blog Highlights Procter & Gamble, Lam Research, Texas Instruments, SandRidge Energy and Crown Crafts

Press Releases

PG, LRCX, TXN, SD and CRWS headline Zacks' latest research, highlighting consumer resilience, semiconductor momentum and micro-cap contrasts.

TXNNegative Net Change PGNegative Net Change LRCXNegative Net Change SDPositive Net Change CRWSNo Net Change